로딩 중…
지수 로딩 중…
Corvus Pharmaceuticals, Inc.
CRVS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$11.91-0.75%
2026-06-18
Price Chart
Corvus Pharmaceuticals, Inc.+203.05%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.00B |
| Revenue | $0.00 |
| Net Income | $-44M |
| Total Assets | $253M |
| Net Assets | $241M |
| Value | |
| P/B | 4.16x |
| FCF Yield | -3.51% |
| Profitability | |
| ROE | -18.35% |
| ROA | -17.44% |
| Earnings Growth | -190.12% |
| Financial Health | |
| Debt Ratio | 5.20% |
| Total Debt | $834000.00 |
| FCF | $-35M |
| Cash | $40M |
| Current Ratio | 19.81x |
| Performance | |
| 1Y Return | 203.05% |
| 1M Return | 3.57% |
| From 52W High | -55.81% |
| 1Y MDD | -56.43% |
| Trading | |
| Volume | 1,625,698 shares |
| Trading Value | $20M |
| Per Share | |
| EPS | $-0.19 |
| BPS | $0.78 |